...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >A review and critique of the EPA's rationale for a fine particle standard.
【24h】

A review and critique of the EPA's rationale for a fine particle standard.

机译:对EPA对微粒标准的基本原理的评论和评论。

获取原文
获取原文并翻译 | 示例
           

摘要

I review the rationale for the Environmental Protection Agency's 1996 fine particle standard, which was based almost entirely on the epidemiological data with neither support from Toxicology nor understanding of mechanism. While many epidemiological papers available in 1996 reported associations between ambient particles and adverse effects on human health, many others did not and the evidence fell far short of supporting a causal association between particle mass concentration and human health. The literature appearing after 1996 further complicates the picture. The large studies that have appeared after 1996, such as National Mortality Morbidity and Air Pollution Study, and the reanalyses of the American Cancer Society II study, report risks that are substantially smaller than the risks reported in the 1996 Criteria Document and Staff Paper. Moreover, concerns about confounding by weather, temporal trends and co-pollutants remain unresolved. Other issues having to do with model choice have resurfacedas a result of reanalyses of critical data to address a glitch in a widely used software package for time-series epidemiology studies of air pollution. Finally, contemporary examples show that the results of observational epidemiology studies can be seriously biased, particularly when estimated risks are small, as is the case with studies of air pollution. The Agency has largely ignored these issues. I conclude that a particle mass standard is not defensible on the basis of a causal association between ambient particle mass and adverse effects on human health. Such a standard may be justifiable on the basis of the precautionary principle, however. The Agency could argue that the Science raises concerns about current levels of air pollution, and that reduction of ambient fine particulate matter mass, if it could be achieved without an increase in the level of the ultrafines, could have positive effects on human health. If the Agency justifies a particulate matter mass standard on these grounds then the debate over the form and level of the standard will, for all practical purposes, belong strictly in the Policy arena.
机译:我回顾了环境保护署1996年细颗粒物标准的基本原理,该标准几乎完全基于流行病学数据,既没有毒理学的支持,也没有机理的理解。尽管1996年有许多流行病学论文报道了环境颗粒与对人类健康的不利影响之间的联系,但许多其他研究却没有,证据还不足以支持颗粒物质量浓度与人类健康之间的因果关系。 1996年以后出现的文献使情况更加复杂。 1996年后出现的大型研究,例如《美国国家死亡率和空气污染研究》,以及对美国第二次癌症研究的重新分析,报告的风险远小于1996年《标准文件》和《员工论文》中报道的风险。此外,对于由天气,时间趋势和共同污染物引起的混淆的担忧仍未解决。与模型选择有关的其他问题再次浮出水面,是对关键数据进行重新分析以解决空气污染的时序流行病学研究中广泛使用的软件包中出现的故障的结果。最后,当代的例子表明,观察流行病学研究的结果可能会产生严重偏差,尤其是当估计的风险较小时,尤其是在空气污染研究中。原子能机构基本上忽略了这些问题。我得出结论,基于环境粒子质量与对人类健康的不利影响之间的因果关系,无法制定粒子质量标准。但是,根据预防原则,这种标准是合理的。原子能机构可能会辩称,《科学》引起了人们对当前空气污染水平的关注,如果能够在不增加超细颗粒水平的情况下实现环境细颗粒物质量的减少,则可能对人类健康产生积极影响。如果原子能机构基于这些理由为颗粒物质量标准辩护,那么出于所有实际目的,对标准形式和水平的辩论将严格属于政策领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号